开放政府环境下医药公司与医生之间的价值转移  

Transfer of value from pharmaceutical industry to physicians in open government survey

作　　者：那旭[1] 郭海红[1] 李姣[1] NA Xu GUO Haihong LI Jiao(Institute of Medical Information, Chinese Academy of Medical Science, Beijing 100020, China)

机构地区：[1]中国医学科学院医学信息研究所,北京100020

出　　处：《大数据》2017年第3期103-111,共9页Big Data Research

基　　金：国家科技基础条件平台中心"国家人口与健康科学数据共享服务平台"基金资助项目;中国工程科技知识中心(医药卫生分中心)基金资助项目~~

摘　　要：医药公司与医生之间价值转移引起的潜在利益冲突能够显著影响临床护理、研究结果和医生临床决策。为了提升医生和医药学行业之间价值转移的透明度,从数据资源、开放共享情况、价值转移类型界定和数据开放政策保障4个方面介绍美国开放资助项目和英国信息披露数据共享的基本情况以及国际上应用价值转移资助数据共享开展的应用研究情况,讨论了数据共享的特色与存在的问题,提出了对我国医药公司开放资助数据行动的启示。Potential conflicts of interest arising from the transfer of value between pharmaceutical industry and physicians could significantly affect clinical care, research findings and physician decision-making. To enhance the transparency of the transfer of value between pharmaceutical industry and physicians, the open payments program of USA and disclosure UK datasets from four aspects： data resources, open status, type of transfer of value and policy guarantee were introduced. In addition, the international research advances based on the datasets were also reviewed. At last, the characteristics and existing problems of the datasets were discussed. The inspiration for China was proposed.

关 键 词：数据共享 医药公司 医生 价值转移 

分 类 号：G203[文化科学—传播学]